To date, several druggable molecules have been described to play roles in AAA development, progression, and rupture, such as the matrix metalloproteinase (MMP) family, transforming growth factor beta receptor 2 (TGFBR2), and sortilin 1 (SORT1) [10]. This evidence concerns the gene TGFBR2 and triple-A syndrome.